TrovaGene Stikes A Preferred Provider Deal With Stratose

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

TrovaGene Inc (NASDAQ: TROV) said that it struck a deal with Stratose, Inc. creating in-network health plan access to its suite of Precision Cancer Monitoring tests, as well as, services. According to the company, Stratose maintained its position of one of the biggest directly managed PPO networks in the America. That helped to administer health benefits for over 8.6 million covered lives.TrovaGene's Chief Commercial Officer, Matt Posard, said, "We are pleased that Stratose has included us as a preferred provider in their healthcare delivery network.' He added, "We continue to execute on our strategy to commercialize our novel liquid biopsy platform and to improve the care of cancer patients with our non-invasive tests for the detection and monitoring of medically relevant oncogene mutations."On Friday, the stock slipped 2.53%.

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!